Osteoimmunology and osteoporosis

Arthritis Research and Therapy

Volumn 13, Issue 5, 2011, Pages

  Geusens, Piet ^a,b   Lems, Willem F ^c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HASSELT UNIVERSITY   (Belgium)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN; CALCITRIOL; CALCIUM; CELECOXIB; DENOSUMAB; DICKKOPF 1 PROTEIN; GLUCOCORTICOID; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 23; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PREDNISONE; RISEDRONIC ACID; STRONTIUM RANELATE; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN; ZOLEDRONIC ACID;

ANKYLOSING SPONDYLITIS; B LYMPHOCYTE; BONE DENSITY; BONE REMODELING; BONE STRUCTURE; BONE TURNOVER; CELL INTERACTION; CORTICOSTEROID INDUCED OSTEOPOROSIS; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG MEGADOSE; DRUG TARGETING; ENTHESITIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOHISTOLOGY; IMMUNOLOGY; INTERVERTEBRAL ARTICULATION; INTERVERTEBRAL DISK; MOLECULAR INTERACTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSSIFICATION; OSTEITIS; OSTEOBLAST; OSTEOCLASTOGENESIS; OSTEOIMMUNOLOGY; OSTEOLYSIS; OSTEOPOROSIS; PATHOLOGICAL ANATOMY; PERIARTICULAR JOINT DISEASE; POSTMENOPAUSE OSTEOPOROSIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SACROILIAC JOINT; SPONDYLOARTHROPATHY; VASCULARIZATION; VERTEBRA FRACTURE; ANIMAL; OSTEOCLAST; PATHOLOGY;

ANIMALS; BONE RESORPTION; HUMANS; OSTEOCLASTS; OSTEOPOROSIS;

EID: 80053988027     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3375     Document Type: Review

References (184)

1. Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol 2009, 5:667-676. 10.1038/nrrheum.2009.217, 19884898.
2. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 1998, 188:997-1001. 10.1084/jem.188.5.997, 2213394, 9730902.
3. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176. 10.1016/S0092-8674(00)81569-X, 9568710.
4. Lorenzo J, Horowitz M, Choi Y. Osteoimmunology: interactions of the bone and immune system. Endocr Rev 2008, 29:403-40. 10.1210/er.2007-0038, 2528852, 18451259.
5. Lorenzo J, Choi Y, Horowitz M, Takayanagi H, . Editors Osteoimmunology 2011, London: Academic Press, Elsevier Inc., Editors.
6. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994, 4:368-381. 10.1007/BF01622200, 7696835.
7. Sommer OJ, Kladosek A, Weiler V, Czembirek H, Boeck M, Stiskal M. Rheumatoid arthritis: a practical guide to state-of-the-art imaging, image interpretation, and clinical implications. Radiographics 2005, 25:381-398. 10.1148/rg.252045111, 15798057.
8. Ejbjerg B, Narvestad E, Rostrup E, Szkudlarek M, Jacobsen S, Thomsen HS, Østergaard M. Magnetic resonance imaging of wrist and finger joints in healthy subjects occasionally shows changes resembling erosions and synovitis as seen in rheumatoid arthritis. Arthritis Rheum 2004, 50:1097-1106. 10.1002/art.20135, 15077291.
9. Stach CM, Bäuerle M, Englbrecht M, Kronke G, Engelke K, Manger B, Schett G. Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography. Arthritis Rheum 2010, 62:330-339.
10. McGonagle D, Tan AL, Moller Døhn U, Ostergaard M, Benjamin M. Microanatomic studies to define predictive factors for the topography of periarticular erosion formation in inflammatory arthritis. Arthritis Rheum 2009, 60(4):1042-1051. 10.1002/art.24417, 19333927, 19333927.
11. Benjamin M, Toumi H, Suzuki D, Redman S, Emery P, McGonagle D. Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondylarthritides and allied disorders. Arthritis Rheum 2007, 56:224-233. 10.1002/art.22290, 17195226.
12. François RJ, Dhem A. Microradiographic study of the normal human vertebral body. Acta Anat (Basel) 1974, 89:251-265.
13. Raisz LG. What marrow does to bone. N Engl J Med 1981, 304:1485-1486. 10.1056/NEJM198106113042410, 7231480.
14. Colburn NT, Zaal KJ, Wang F, Tuan RS. A role for gamma/delta T cells in a mouse model of fracture healing. Arthritis Rheum 2009, 60:1694-1703. 10.1002/art.24520, 2697263, 19479830.
15. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846. 10.1038/nature02040, 14574413.
16. Frisch BJ, Porter RL, Calvi LM. Hematopoietic niche and bone meet. Curr Opin Support Palliat Care 2008, 2:211-217. 10.1097/SPC.0b013e32830d5c12, 2572865, 18685423.
17. Yin T, Li L. The stem cell niches in bone. J Clin Invest 2006, 116:1195-1201. 10.1172/JCI28568, 1451221, 16670760.
18. Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC, Kos CH, Pollak MR, Brown EM, Scadden DT. Stem cell engraftment at the endosteal niche is specified by the calciumsensing receptor. Nature 2006, 439:599-603. 10.1038/nature04247, 16382241.
19. Lories RJ, Luyten FP. Bone morphogenetic proteins in destructive and remodeling arthritis. Arthritis Res Ther 2007, 9:207. 10.1186/ar2135, 1906799, 17381828.
20. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007, 13:156-163. 10.1038/nm1538, 17237793.
21. Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, Haibel H, Baraliakos X, Hempfing A, Rudwaleit M, Sieper J, Schett G. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 2009, 60:3257-3262. 10.1002/art.24888, 19877044.
22. Goldring SR, Schett G. The role of the immune system in bone loss of inflammatory arthritis. Osteoimmunology 2011, 301-324. London: Academic Press, Elsevier Inc., Lorenzo J, Choi Y, Horowitz M, Takayanagi H.
23. Herman S, Müller RB, Kronke G, Zwerina J, Redlich K, Hueber AJ, Gelse H, Neumann E, Müller-Ladner U, Schett G. Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis. Arthritis Rheum 2008, 58:3041-3050. 10.1002/art.23943, 18821671.
24. Nemeth K, Schoppet M, Al-Fakhri N, Helas S, Jessberger R, Hofbauer LC, Goettsch C. The role of osteoclast-associated receptor in osteoimmunology. J Immunol 2011, 186:13-18. 10.4049/jimmunol.1002483, 21172874.
25. Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, Yiannopoulos G, Andonopoulos AP. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 2010, 62:150-158. 10.1002/art.27231, 20039407.
26. Chen HA, Chen CH, Lin YJ, Chen PC, Chen WS, Lu CL, Chou CT. Association of bone morphogenetic proteins with spinal fusion in ankylosing spondylitis. J Rheumatol 2010, 37:2126-2132. 10.3899/jrheum.100200, 20682677.
27. Vosse D, Landewé R, Garnero P, van der Heijde D, van der Linden S, Geusens P. Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis. Rheumatology (Oxford) 2008, 47:1219-1222.
28. Braun J, Baraliakos X. Imaging of axial spondyloarthritis including ankylosing spondylitis. Ann Rheum Dis 2011, 70(Suppl 1):i97-103. 10.1136/ard.2010.140541, 21339229.
29. Teitelbaum SL. Postmenopausal osteoporosis, T cells, and immune dysfunction. Proc Natl Acad Sci USA 2004, 101:16711-16712. 10.1073/pnas.0407335101, 534741, 15557556.
30. Leisen JC, Duncan H, Riddle JM, Pitchford WC. The erosive front: a topographic study of the junction between the pannus and the subchondral plate in the macerated rheumatoid metacarpal head. J Rheumatol 1988, 15:17-22.
31. Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:1068-1076.
32. Bywaters EG. The early radiological signs of rheumatoid arthritis. Bull Rheum Dis 1960, 11:231-234.
33. Jimenez-Boj E, Nöbauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus AH, Kainberger F, Trattnig S, Axmann R, Tsuji W, Hermann S, Smolen J, Schett G. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 2007, 56:1118-1124. 10.1002/art.22496, 17393390.
34. Reid DM, Kennedy NS, Smith MA, Tothill P, Nuki G. Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J (Clin Res Ed) 1982, 285:330-332.
35. Engfeldt B, Romanus R, Yden S. Histological studies of pelvo-spondylitis ossificans (ankylosing spondylitis) correlated with clinical and radiological findings. Ann Rheum Dis 1954, 13:219-228. 10.1136/ard.13.3.219, 1006738, 13198056.
36. François RJ, Gardner DL, Degrave EJ, Bywaters EG. Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis. Arthritis Rheum 2000, 43:2011-2024. 10.1002/1529-0131(200009)43:9<2011::AID-ANR12>3.0.CO;2-Y, 11014351.
37. Aufdermaur M. Pathogenesis of square bodies in ankylosing spondylitis. Ann Rheum Dis 1989, 48:628-631. 10.1136/ard.48.8.628, 1003836, 2782972.
38. Rudwaleit M, Jurik AG, Hermann KG, Landewé R, van der Heijde D, Baraliakos X, Marzo-Ortega H, Ostergaard M, Braun J, Sieper J. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009, 68:1520-1527. 10.1136/ard.2009.110767, 19454404.
39. Zochling J, Baraliakos X, Hermann KG, Braun J. Magnetic resonance imaging in ankylosing spondylitis. Curr Opin Rheumatol 2007, 19:346-352. 10.1097/BOR.0b013e32816a938c, 17551364.
40. Baraliakos X, Landewé R, Hermann KG, Listing J, Golder W, Brandt J, Rudwaleit M, Bollow M, Sieper J, van der Heijde D, Braun J. Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging. Ann Rheum Dis 2005, 4:730-734.
41. Maksymowych WP. MRI in ankylosing spondylitis. Curr Opin Rheumatol 2009, 21:313-317. 10.1097/BOR.0b013e32832af481, 19496307.
42. Maksymowych WP. Progress in spondylarthritis. Spondyloarthritis: lessons from imaging. Arthritis Res Ther 2009, 11:222. 10.1186/ar2665, 2714098, 19519927.
43. Cruickshank B. Lesions of cartilaginous joints in ankylosing spondylitis. J Pathol Bacteriol 1956, 71:73-84. 10.1002/path.1700710111, 13307336.
44. Appel H, Loddenkemper C, Grozdanovic Z, Ebhardt H, Dreimann M, Hempfing A, Stein H, Metz-Stavenhagen P, Rudwaleit M, Sieper J. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006, 8:R143. 10.1186/ar2035, 1779434, 16925803.
45. Appel H, Kuhne M, Spiekermann S, Ebhardt H, Grozdanovic Z, Köhler D, Dreimann M, Hempfing A, Rudwaleit M, Stein H, Metz-Stavenhagen P, Sieper J, Loddenkemper C. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 2006, 54:2845-2851. 10.1002/art.22060, 16947385.
46. Benjamin M, McGonagle D. The enthesis organ concept and its relevance to the spondyloarthropathies. Adv Exp Med Biol 2009, 649:57-70. 10.1007/978-1-4419-0298-6_4, 19731620.
47. McGonagle D, Gibbon W, Emery P. Classification of inflammatory arthritis by enthesitis. Lancet 1998, 352:1137-1140. 10.1016/S0140-6736(97)12004-9, 9798608.
48. Walsh NC, Reinwald S, Manning CA, Condon KW, Iwata K, Burr DB, Gravallese EM. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res 2009, 24:1572-1585. 10.1359/jbmr.090320, 19338457.
49. Møller Døhn U, Boonen A, Hetland ML, Hansen MS, Knudsen LS, Hansen A, Madsen OR, Hasselquist M, Møller JM, Østergaard M. Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure. Ann Rheum Dis 2009, 68:1585-1590. 10.1136/ard.2008.097048, 19019887.
50. François RJ. Microradiographic study of the intervertebral bridges in ankylosing spondylitis and in the normal sacrum. Ann Rheum Dis 1965, 24:481-489. 10.1136/ard.24.5.481, 1031014, 5834231.
51. Sambrook PN, Ansell BM, Foster S, Gumpel JM, Hesp R, Reeve J, Zanelli JM. Bone turnover in early rheumatoid arthritis. 1. Biochemical and kinetic indexes. Ann Rheum Dis 1985, 44:575-579. 10.1136/ard.44.9.575, 1001712, 3876076.
52. Garnero P, Delmas PD. Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers. Curr Opin Rheumatol 2004, 16:428-434. 10.1097/01.moo.0000127830.72761.00, 15201607.
53. Geusens PP, Landewé RB, Garnero P, Chen D, Dunstan CR, Lems WF, Stinissen P, van der Heijde DM, van der Linden S, Boers M. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum 2006, 54:1772-1777. 10.1002/art.21896, 16736519.
54. van Tuyl LH, Voskuyl AE, Boers M, Geusens P, Landewé RB, Dijkmans BA, Lems WF. Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. Ann Rheum Dis 2010, 69:1623-1628. 10.1136/ard.2009.121764, 20525836.
55. Hall GM, Spector TD, Delmas PD. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. Arthritis Rheum 1995, 38:902-906. 10.1002/art.1780380705, 7612039.
56. Deodhar AA, Woolf AD. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 1996, 35:309-322. 10.1093/rheumatology/35.4.309, 8624634.
57. El Maghraoui A, Borderie D, Cherruau B, Edouard R, Dougados M, Roux C. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 1999, 26:2205-2209.
58. MacDonald AG, Birkinshaw G, Durham B, Bucknall RC, Fraser WD. Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. Br J Rheumatol 1997, 36:50-53. 10.1093/rheumatology/36.1.50, 9117174.
59. Stupphann D, Rauner M, Krenbek D, Patsch J, Pirker T, Muschitz C, Resch H, Pietschmann P. Intracellular and surface RANKL are differentially regulated in patients with ankylosing spondylitis. Rheumatol Int 2008, 28:987-993. 10.1007/s00296-008-0567-y, 18369625.
60. Franck H, Meurer T, Hofbauer LC. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 2004, 31:2236-2241.
61. Appel H, Maier R, Loddenkemper C, Kayser R, Meier O, Hempfing A, Sieper J. Immunohistochemical analysis of osteoblasts in zygapophyseal joints of patients with ankylosing spondylitis reveal repair mechanisms similar to osteoarthritis. J Rheumatol 2010, 37:823-828. 10.3899/jrheum.090986, 20156950.
62. Vandooren B, Cantaert T, Noordenbos T, Tak PP, Baeten D. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Arthritis Rheum 2008, 58:718-729. 10.1002/art.23290, 18311801.
63. Arends S, Spoorenberg A, Bruyn GA, Houtman PM, Leijsma MK, Kallenberg CG, Brouwer E, van der Veer E. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis. Osteoporos Int 2011, 22:1431-1439. 10.1007/s00198-010-1338-7, 3073049, 20603707.
64. Njeh CF, Genant HK. Bone loss. Quantitative imaging techniques for assessing bone mass in rheumatoid arthritis. Arthritis Res 2000, 2:446-50. 10.1186/ar126, 128873, 11094457.
65. Rosholm A, Hyldstrup L, Backsgaard L, Grunkin M, Thodberg HH. Estimation of bone mineral density by digital X-ray radiogrammetry: theoretical background and clinical testing. Osteoporos Int 2001, 12:961-969. 10.1007/s001980170026, 11804024.
66. Deodhar AA, Brabyn J, Jones PW, Davis MJ, Woolf AD. Measurement of hand bone mineral content by dual energy x-ray absorptiometry: development of the method, and its application in normal volunteers and in patients with rheumatoid arthritis. Ann Rheum Dis 1994, 53:685-690. 10.1136/ard.53.10.685, 1005437, 7979583.
67. Böttcher J, Pfeil A, Mentzel H, Kramer A, Schäfer ML, Lehmann G, Eidner T, Petrovitch A, Malich A, Hein G, Kaiser WA. Peripheral bone status in rheumatoid arthritis evaluated by digital X-ray radiogrammetry and compared with multisite quantitative ultrasound. Calcif Tissue Int 2006, 78:25-34. 10.1007/s00223-005-0175-8, 16397736.
68. Lespessailles E, Gadois C, Lemineur G, Do-Huu JP, Benhamou L. Bone texture analysis on direct digital radiographic images: precision study and relationship with bone mineral density at the oscalcis. Calcif Tissue Int 2007, 80:97-102. 10.1007/s00223-006-0216-y, 17308991.
69. El Maghraoui A, Rezqi A, Mounach A, Achemlal L, Bezza A, Ghozlani I. Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment. Rheumatology (Oxford) 2010, 49:1303-1310.
70. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ, O'Neill T, Pols H, Reeve J, Silman A, Tenenhouse A. Predictive value of BMD for hip and other fractures. J Bone Miner Res 2005, 20:1185-1194. Erratum in: J Bone Miner Res 2007, 22:774., 10.1359/JBMR.050304, 15940371.
71. Baraliakos X, Hermann KG, Landewé R, Listing J, Golder W, Brandt J, Rudwaleit M, Bollow M, Sieper J, van der Heijde D, Braun J. Assessment of acute spinal infl ammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis 2005, 64:1141-1144. 10.1136/ard.2004.031609, 1755589, 15650011.
72. Baraliakos X, Listing J, Rudwaleit M, Haibel H, Brandt J, Sieper J, Braun J. Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis 2007, 66:910-915. 10.1136/ard.2006.066415, 1955120, 17329306.
73. Fouque-Aubert A, Chapurlat R, Miossec P, Delmas PD. A comparative review of the different techniques to assess hand bone damage in rheumatoid arthritis. Joint Bone Spine 2010, 77:212-217. 10.1016/j.jbspin.2009.08.009, 20381399.
74. Dihlman W. Joints and Vertebral Connections 1985, New York: Thieme Inc..
75. Roux C. Osteoporosis in inflammatory joint diseases. Osteoporos Int 2011, 22:421-433. 10.1007/s00198-010-1319-x, 21574050.
76. Hoff M, Haugeberg G. Using hand bone measurements to assess progression of rheumatoid arthritis. Therapeutic Advances in Musculoskeletal Disease 2010, 79-88.
77. Alenfeld FE, Diessel E, Brezger M, Sieper J, Felsenberg D, Braun J. Detailed analyses of periarticular osteoporosis in rheumatoid arthritis. Osteoporos Int 2000, 11:400-407. 10.1007/s001980070106, 10912841.
78. Sambrook PN, Ansell BM, Foster S, Gumpel JM, Hesp R, Reeve J. Bone turnover in early rheumatoid arthritis. 2. Longitudinal bone density studies. Ann Rheum Dis 1985, 44:580-584. 10.1136/ard.44.9.580, 1001713, 3876077.
79. Laan RF, Buijs WC, van Erning LJ, Lemmens JA, Corstens FH, Ruijs SH, van de Putte LB, van Riel PL. Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content. Calcif Tissue Int 1993, 52:5-9. 10.1007/BF00675619, 8453505.
80. Inaba M, Nagata M, Goto H, Kumeda Y, Kobayashi K, Nakatsuka K, Miki T, Yamada S, Ishimura E, Nishizawa Y. Preferential reductions of paraarticular trabecular bone component in ultradistal radius and of calcaneus ultrasonography in early-stage rheumatoid arthritis. Osteoporos Int 2003, 14:683-687. 10.1007/s00198-003-1427-y, 12879221.
81. Hoff M, Haugeberg G, Odegård S, Syversen S, Landewé R, van der Heijde D, Kvien TK. Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann Rheum Dis 2009, 68:324-329. 10.1136/ard.2007.085985, 18339664.
82. Haugeberg G, Green MJ, Quinn MA, Marzo-Ortega H, Proudman S, Karim Z, Wakefield RJ, Conaghan PG, Stewart S, Emery P. Hand bone loss in early undifferentiated arthritis: evaluating bone mineral density loss before the development of rheumatoid arthritis. Ann Rheum Dis 2006, 65:736-740. 10.1136/ard.2005.043869, 1798164, 16284095.
83. Bøyesen P, Hoff M, Odegård S, Haugeberg G, Syversen SW, Gaarder PI, Okkenhaug C, Kvien TK. Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study. Arthritis Res Ther 2009, 11:R103. 10.1186/ar2749, 2745778, 19570223.
84. Jawaid WB, Crosbie D, Shotton J, Reid DM, Stewart A. Use of digital x ray radiogrammetry in the assessment of joint damage in rheumatoid arthritis. Ann Rheum Dis 2006, 65:459-464. 10.1136/ard.2005.039792, 1798109, 16126795.
85. Haugeberg G, Lodder MC, Lems WF, Uhlig T, Ørstavik RE, Dijkmans BA, Kvien TK, Woolf AD. Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50-70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study. Ann Rheum Dis 2004, 63:1331-1334. 10.1136/ard.2003.015065, 1754746, 15361395.
86. Bouxsein ML, Palermo L, Yeung C, Black DM. Digital X-ray radiogrammetry predicts hip, wrist and vertebral fracture risk in elderly women: a prospective analysis from the study of osteoporotic fractures. Osteoporos Int 2002, 13:358-365. 10.1007/s001980200040, 12086345.
87. McQueen FM, Dalbeth N. Predicting joint damage in rheumatoid arthritis using MRI scanning. Arthritis Res Ther 2009, 11:124. 10.1186/ar2778, 2787290, 19796371.
88. Bøyesen P, Haavardsholm EA, Ostergaard M, van der Heijde D, Sesseng S, Kvien TK. MRI in early rheumatoid arthritis: synovitis and bone marrow oedema are independent predictors of subsequent radiographic progression. Ann Rheum Dis 2011, 70:428-433. 10.1136/ard.2009.123950, 20810395.
89. McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, McLean L. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis 1998, 57:350-356. 10.1136/ard.57.6.350, 1752612, 9771209.
90. McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, McLean L, Stewart N. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003, 48:1814-1827. 10.1002/art.11162, 12847674.
91. Hodgson RJ, O'Connor P, Moots R. MRI of rheumatoid arthritis image quantitation for the assessment of disease activity, progression and response to therapy. Rheumatology (Oxford) 2008, 47:13-21.
92. Bird P, Conaghan P, Ejbjerg B, McQueen F, Lassere M, Peterfy C, Edmonds J, Shnier R, O'Connor P, Haavardsholm E, Emery P, Genant H, Østergaard M. The development of the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis 2005, 64(Suppl 1):i8-10. 1766830, 15647422.
93. Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, Fujikawa K, Aramaki T, Kawashiri SY, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Aoyagi K, Eguchi K. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum 2009, 61:772-778. 10.1002/art.24711, 19479686.
94. Hetland ML, Ejbjerg B, Hørslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Skjødt H, Pedersen JK, Majgaard O, Svendsen AJ, Ellingsen T, Lindegaard H, Christensen AF, Vallø J, Torfing T, Narvestad E, Thomsen HS, Ostergaard M, . CIMESTRA study group MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis 2009, 68:384-390. 10.1136/ard.2008.088245, 18388160, CIMESTRA study group.
95. McQueen FM, Gao A, Ostergaard M, King A, Shalley G, Robinson E, Doyle A, Clark B, Dalbeth N. High-grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone. Ann Rheum Dis 2007, 66:1581-1587. 10.1136/ard.2007.070326, 2095325, 17491098.
96. Dalbeth N, Smith T, Gray S, Doyle A, Antill P, Lobo M, Robinson E, King A, Cornish J, Shalley G, Gao A, McQueen FM. Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann Rheum Dis 2009, 68:279-282. 10.1136/ard.2008.096024, 18765428.
97. Oelzner P, Schwabe A, Lehmann G, Eidner T, Franke S, Wolf G, Hein G. Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int 2008, 28:1143-1150. 10.1007/s00296-008-0576-x, 18446340.
98. Lane NE, Pressman AR, Star VL, Cummings SR, Nevitt MC. Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1995, 10:257-263.
99. Kröger H, Honkanen R, Saarikoski S, Alhava E. Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis - a population based study. Ann Rheum Dis 1994, 53:18-23. 10.1136/ard.53.1.18, 1005237, 8311549.
100. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 2000, 43:522-30. 10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y, 10728744.
101. Bhalla AK, Shenstone B. Bone densitometry measurements in early inflammatory disease. Baillieres Clin Rheumatol 1992, 6:405-414. 10.1016/S0950-3579(05)80182-7, 1525845.
102. Hanley DA, Brown JP, Tenenhouse A, Olszynski WP, Ioannidis G, Berger C, Prior JC, Pickard L, Murray TM, Anastassiades T, Kirkland S, Joyce C, Joseph L, Papaioannou A, Jackson SA, Poliquin S, Adachi JD, . Canadian Multicentre Osteoporosis Study Research Group Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res 2003, 18:784-790. 10.1359/jbmr.2003.18.4.784, 12674340, Canadian Multicentre Osteoporosis Study Research Group.
103. Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ronday HK, Peeters AJ, de Jonge-Bok JM, Breedveld FC, Dijkmans BA, Allaart CF, Lems WF. Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis. Ann Rheum Dis 2007, 66:1508-1512. 10.1136/ard.2007.070839, 2111640, 17456523.
104. Guler H, Turhanoglu AD, Ozer B, Ozer C, Balci A. The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis. Scand J Rheumatol 2008, 37:337-342. 10.1080/03009740801998812, 18609264.
105. Wijbrandts CA, Klaasen R, Dijkgraaf MG, Gerlag DM, van Eck-Smit BL, Tak PP. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss. Ann Rheum Dis 2009, 68:373-376. 10.1136/ard.2008.091611, 2945478, 18408246.
106. Forslind K, Keller C, Svensson B, Hafström I, . BARFOT Study Group Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women. J Rheumatol 2003, 30:2590-2596. BARFOT Study Group.
107. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994, 344:23-27. 10.1016/S0140-6736(94)91049-9, 7912297.
108. Kroot EJ, Nieuwenhuizen MG, de Waal Malefijt MC, van Riel PL, Pasker-de Jong PC, Laan RF. Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. Arthritis Rheum 2001, 44:1254-1260. 10.1002/1529-0131(200106)44:6<1254::AID-ART216>3.0.CO;2-G, 11407683.
109. Lodder MC, Haugeberg G, Lems WF, Uhlig T, Orstavik RE, Kostense PJ, Dijkmans BA, Kvien TK, Woolf AD, . Oslo-Truro-Amsterdam (OSTRA) Collaborative Study Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. Arthritis Rheum 2003, 49:209-215. 10.1002/art.10996, 12687512, Oslo-Truro-Amsterdam (OSTRA) Collaborative Study.
110. Lodder MC, de Jong Z, Kostense PJ, Molenaar ET, Staal K, Voskuyl AE, Hazes JM, Dijkmans BA, Lems WF. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis 2004, 63:1576-1580. 10.1136/ard.2003.016253, 1754831, 15547081.
111. Solomon DH, Finkelstein JS, Shadick N, LeBoff MS, Winalski CS, Stedman M, Glass R, Brookhart MA, Weinblatt ME, Gravallese EM. The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 2009, 60:1624-1631. 10.1002/art.24551, 2748798, 19479876.
112. Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995, 54:801-806. 10.1136/ard.54.10.801, 1010013, 7492217.
113. van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006, 54:3104-3112. 10.1002/art.22117, 17009229.
114. Vis M, Haavardsholm EA, Bøyesen P, Haugeberg G, Uhlig T, Hoff M, Woolf A, Dijkmans B, Lems W, Kvien TK. High incidence of vertebral and nonvertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis. Osteoporos Int 2011,
115. Ghazi M, Kolta S, Briot K, Fechtenbaum J, Paternotte S, Roux C. Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Osteoporos Int 2011,
116. Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang CL, Garneau K, Solomon DH. Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther 2010, 12:R154. 10.1186/ar3107, 2945054, 20682035.
117. Sinigaglia L, Varenna M, Girasole G, Bianchi G. Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin North Am 2006, 32:631-658. 10.1016/j.rdc.2006.07.002, 17288969.
118. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008, 19:385-397. 10.1007/s00198-007-0543-5, 2267485, 18292978.
119. Kay LJ, Holland TM, Platt PN. Stress fractures in rheumatoid arthritis: a case series and case-control study. Ann Rheum Dis 2004, 63:1690-1692. 10.1136/ard.2003.010322, 1754845, 15547098.
120. Michel BA, Bloch DA, Wolfe F, Fries JF. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 1993, 20:1666-1669.
121. Coulson KA, Reed G, Gilliam BE, Kremer JM, Pepmueller PH. Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol 2009, 15:155-160. 10.1097/RHU.0b013e3181a5679d, 19363452.
122. Haugeberg G, Ørstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK. Clinical decision rules in rheumatoid arthritis: do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis Register. Ann Rheum Dis 2002, 61:1085-1089. 10.1136/ard.61.12.1085, 1753963, 12429540.
123. Cauley JA, Danielson ME, Boudreau RM, Forrest KY, Zmuda JM, Pahor M, Tylavsky FA, Cummings SR, Harris TB, Newman AB, . for the Health ABC Study Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res 2007, 22:1088-1095. 10.1359/jbmr.070409, 17419681, for the Health ABC Study.
124. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res 1996, 11:1531-1538.
125. Hayashibara M, Hagino H, Katagiri H, Okano T, Okada J, Teshima R. Incidence and risk factors of falling in ambulatory patients with rheumatoid arthritis: a prospective 1-year study. Osteoporos Int 2010, 21:1825-1833. 10.1007/s00198-009-1150-4, 20119662.
126. van den Bergh JP, van Geel TA, Lems WF, Geusens PP. Assessment of individual fracture risk: FRAX and beyond. Curr Osteoporos Rep 2010, 8:131-137. 10.1007/s11914-010-0022-3, 2902745, 20563901.
127. Brand C, Lowe A, Hall S. The utility of clinical decision tools for diagnosing osteoporosis in postmenopausal women with rheumatoid arthritis. BMC Musculoskelet Disord 2008, 9:13. 10.1186/1471-2474-9-13, 2270830, 18230132.
128. Deodhar AA, Brabyn J, Jones PW, Davis MJ, Woolf AD. Longitudinal study of hand bone densitometry in rheumatoid arthritis. Arthritis Rheum 1995, 38:1204-1210. 10.1002/art.1780380905, 7575713.
129. Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, Dijkmans BA, Woolf AD, Kvien TK, Lems WF. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis 2006, 65:1495-1499. 10.1136/ard.2005.044198, 1798341, 16606653.
130. Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Hulsmans HM, de Beus WM, Han KH, Breedveld FC, Dijkmans BA, Allaart CF, Lems WF. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis. Ann Rheum Dis 2008, 67:823-828. 10.1136/ard.2007.073817, 17644545.
131. Lodder MC, Van Pelt PA, Lems WF, Kostense PJ, Koks CH, Dijkmans BA. Effects of high dose IV pamidronate on disease activity and bone metabolism in patients with active RA: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2003, 30:2080-2081.
132. Jarrett SJ, Conaghan PG, Sloan VS, Papanastasiou P, Ortmann CE, O'Connor PJ, Grainger AJ, Emery P. Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis. Arthritis Rheum 2006, 54:1410-1414. 10.1002/art.21824, 16645968.
133. Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R, . Denosumab Rheumatoid Arthritis Study Group Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum 2008, 58:1299-1309. 10.1002/art.23417, 18438830, Denosumab Rheumatoid Arthritis Study Group.
134. Dore RK, Cohen SB, Lane NE, Palmer W, Shergy W, Zhou L, Wang H, Tsuji W, Newmark R, . Denosumab RA Study Group Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates. Ann Rheum Dis 2010, 69:872-875. 10.1136/ard.2009.112920, 19734132, Denosumab RA Study Group.
135. Sharp JT, Tsuji W, Ory P, Harper-Barek C, Wang H, Newmark R. Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010, 62:537-544.
136. Deodhar A, Dore RK, Mandel D, Schechtman J, Shergy W, Trapp R, Ory PA, Peterfy CG, Fuerst T, Wang H, Zhou L, Tsuji W, Newmark R. Denosumabmediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 2010, 62:569-574.
137. Compston J. Management of glucocorticoid-induced osteoporosis. Nat Rev Rheumatol 2010, 6:82-88. 10.1038/nrrheum.2009.259, 20125175.
138. Geusens PP, de Nijs RN, Lems WF, Laan RF, Struijs A, van Staa TP, Bijlsma JW. Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology. Ann Rheum Dis 2004, 63:324-325. 10.1136/ard.2003.008060, 1754904, 14962971.
139. Geusens PP. Review of guidelines for testing and treatment of osteoporosis. Curr Osteoporos Rep 2003, 1:59-65. 10.1007/s11914-003-0010-y, 16036066.
140. Will R, Palmer R, Bhalla AK, Ring F, Calin A. Osteoporosis in early ankylosing spondylitis: a primary pathological event?. Lancet 1989, 2:1483-1485.
141. Lee YS, Schlotzhauer T, Ott SM, van Vollenhoven RF, Hunter J, Shapiro J, Marcus R, McGuire JL. Skeletal status of men with early and late ankylosing spondylitis. Am J Med 1997, 103:233-241. 10.1016/S0002-9343(97)00143-5, 9316556.
142. Karberg K, Zochling J, Sieper J, Felsenberg D, Braun J. Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 2005, 32:1290-1298.
143. Lange U, Kluge A, Strunk J, Teichmann J, Bachmann G. Ankylosing spondylitis and bone mineral density--what is the ideal tool for measurement?. Rheumatol Int 2005, 26:115-120. 10.1007/s00296-004-0515-4, 15538574.
144. Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L, Bezza A, El Maghraoui A. Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 2009, 44:772-776. 10.1016/j.bone.2008.12.028, 19442629.
145. Maillefert JF, Aho LS, El Maghraoui A, Dougados M, Roux C. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int 2001, 12:605-609. 10.1007/s001980170084, 11527060.
146. El Maghraoui A. Osteoporosis and ankylosing spondylitis. Joint Bone Spine 2004, 71:291-295. 10.1016/j.jbspin.2003.06.002, 15288853.
147. Cooper C, Carbone L, Michet CJ, Atkinson EJ, O'Fallon WM, Melton LJ. Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 1994, 21:1877-1882.
148. Vosse D, Landewé R, van der Heijde D, van der Linden S, van Staa TP, Geusens P. Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study. Ann Rheum Dis 2009, 68:1839-1842. 10.1136/ard.2008.100503, 19066179.
149. Vosse D, van der Heijde D, Landewé R, Geusens P, Mielants H, Dougados M, van der Linden S. Determinants of hyperkyphosis in patients with ankylosing spondylitis. Ann Rheum Dis 2006, 65:770-774. 10.1136/ard.2005.044081, 1798162, 16219704.
150. Geusens P, Vosse D, van der Heijde D, Vanhoof J, van Tubergen A, Raus J, van der Linden S. High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis. J Rheumatol 2001, 28:1856-1861.
151. Montala N, Juanola X, Collantes E, Muñoz-Gomariz E, Gonzalez C, Gratacos J, Zarco P, Sueiro JL, Mulero J, Torre-Alonso JC, Batlle E, Carmona L. Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis. J Rheumatol 2011, 38:893-897. 10.3899/jrheum.100851, 21362760.
152. Vosse D, Heijckmann C, Landewé R, van der Heijde D, van der Linden S, Geusens P. Comparing morphometric X-ray absorptiometry and radiography in defining vertebral wedge fractures in patients with ankylosing spondylitis. Rheumatology (Oxford) 2007, 46:1667-1671.
153. Vosse D, Feldtkeller E, Erlendsson J, Geusens P, van der Linden S. Clinical vertebral fractures in patients with ankylosing spondylitis. J Rheumatol 2004, 31:1981-1985.
154. Wang YF, Teng MM, Chang CY, Wu HT, Wang ST. Imaging manifestations of spinal fractures in ankylosing spondylitis. AJNR Am J Neuroradiol 2005, 26:2067-2076.
155. Rudwaleit M, Haibel H, Baraliakos X, Listing J, Märker-Hermann E, Zeidler H, Braun J, Sieper J. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 2009, 60:717-727. 10.1002/art.24483, 19248087.
156. Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, Braun J, Burgos-Vargas R, Collantes-Estevez E, Davis J, Dijkmans B, Dougados M, Emery P, van der Horst-Bruinsma IE, Inman R, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Sturrock R, de Vlam K, Sieper J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009, 68:770-776. 10.1136/ard.2009.108217, 19297345.
157. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle-Oñate R, Weber U, Wei J, Sieper J. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009, 68:777-783. 10.1136/ard.2009.108233, 19297344.
158. Atagunduz P, Aydin SZ, Bahadir C, Erer B, Direskeneli H. Determinants of early radiographic progression in ankylosing spondylitis. J Rheumatol 2010, 37:2356-2361. 10.3899/jrheum.100094, 20843901.
159. Baraliakos X, Listing J, von der Recke A, Braun J. The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients. J Rheumatol 2009, 36:997-1002. 10.3899/jrheum.080871, 19332632.
160. Baraliakos X, Listing J, Rudwaleit M, Sieper J, Braun J. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 2008, 10:R104. 10.1186/ar2496, 2592781, 18761747.
161. Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Østergaard M, Lambert RG. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009, 60:93-102. 10.1002/art.24132, 19116919.
162. Wanders A, Heijde D, Landewé R, Béhier JM, Calin A, Olivieri I, Zeidler H, Dougados M. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005, 52:1756-1765. 10.1002/art.21054, 15934081.
163. Dodwell ER, Latorre JG, Parisini E, Zwettler E, Chandra D, Mulpuri K, Snyder B. NSAID exposure and risk of nonunion: a meta-analysis of case-control and cohort studies. Calcif Tissue Int 2010, 87:193-202. 10.1007/s00223-010-9379-7, 20552333.
164. Simon AM, O'Connor JP. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. J Bone Joint Surg Am 2007, 89:500-511. 10.2106/JBJS.F.00127, 17332098.
165. Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, Skeith KJ, Aaron SL, Homik J, Davis P, Sholter D, Russell AS. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 2002, 46:766-773. 10.1002/art.10139, 11920413.
166. Lories RJ, Derese I, Luyten FP. Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis. Rheumatology (Oxford) 2008, 47:605-608.
167. Sidiropoulos PI, Hatemi G, Song IH, Avouac J, Collantes E, Hamuryudan V, Herold M, Kvien TK, Mielants H, Mendoza JM, Olivieri I, Østergaard M, Schachna L, Sieper J, Boumpas DT, Dougados M. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practicing rheumatologists. Rheumatology (Oxford) 2008, 47:355-361.
168. Visvanathan S, Wagner C, Marini JC, Baker D, Gathany T, Han J, van der Heijde D, Braun J. Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis 2008, 67:511-517. 2564765, 17644552.
169. Schett G, Rudwaleit M. Can we stop progression of ankylosing spondylitis?. Best Pract Res Clin Rheumatol 2010, 24:363-371. 10.1016/j.berh.2010.01.005, 20534370.
170. Schett G, Firestein GS. Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann Rheum Dis 2010, 69:787-789. 10.1136/ard.2009.121657, 20299352.
171. Fujii K, Tsuji M, Tajima M. Rheumatoid arthritis: a synovial disease?. Ann Rheum Dis 1999, 58:727-730. 10.1136/ard.58.12.727, 1752821, 10577956.
172. Hirohata S, Yanagida T, Nagai T, Sawada T, Nakamura H, Yoshino S, Tomita T, Ochi T. Induction of fibroblast-like cells from CD34(+) progenitor cells of the bone marrow in rheumatoid arthritis. J Leukoc Biol 2001, 70:413-421.
173. Hayer S, Polzer K, Brandl A, Zwerina J, Kireva T, Smolen JS, Schett G. B-cell infiltrates induce endosteal bone formation in inflammatory arthritis. J Bone Miner Res 2008, 23:1650-1660. 10.1359/jbmr.080508, 18505368.
174. Horowitz MC, Fretz JA, Lorenzo JA. How B cells influence bone biology in health and disease. Bone 2010, 47:472-479. 10.1016/j.bone.2010.06.011, 2941392, 20601290.
175. Bugatti S, Codullo V, Caporali R, Montecucco C. B cells in rheumatoid arthritis. Autoimmun Rev 2007, 7:137-142. 10.1016/j.autrev.2007.02.017, 18035324.
176. Landewé R, van der Heijde D, Klareskog L, van Vollenhoven R, Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 2006, 54:3119-3125. 10.1002/art.22143, 17009230.
177. Bugatti S, Caporali R, Manzo A, Vitolo B, Pitzalis C, Montecucco C. Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment. Arthritis Rheum 2005, 52:3448-3459. 10.1002/art.21377, 16258900.
178. Drossaers-Bakker KW, Zwinderman AH, Vliet Vlieland TP, Van Zeben D, Vos K, Breedveld FC, Hazes JM. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. Arthritis Rheum 2002, 47:383-390. 10.1002/art.10513, 12209484.
179. Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, van Vollenhoven R, Winthrop KL, Wong J, Zink A, van der Heijde D. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010, 69:964-975. 10.1136/ard.2009.126532, 2935329, 20444750.
180. Mundwiler ML, Maranian P, Brown DH, Silverman JM, Wallace D, Khanna D, Louie J, Furst DE, Weisman MH. The utility of MRI in predicting radiographic erosions in the metatarsophalangeal joints of the rheumatoid foot: a prospective longitudinal cohort study. Arthritis Res Ther 2009, 11:R94. 10.1186/ar2737, 2714150, 19545417.
181. Geusens PP, Lems WF. Measuring metacarpal cortical bone by digital x-ray radiogrammetry: a step forward?. Arthritis Res Ther 2009, 11:127. 10.1186/ar2788, 2787260, 19833006.
182. McGonagle D. The history of erosions in rheumatoid arthritis: are erosions history?. Arthritis Rheum 2010, 62:312-315. 10.1002/art.27199, 20112356.
183. van der Heijde D, Rudwaleit M, Landewé RB, Sieper J. Justification for including MRI as a tool in the diagnosis of axial SpA. Nat Rev Rheumatol 2010, 6:670-672. 10.1038/nrrheum.2010.160, 20924411.
184. De Rycke L, Maas M, Tak PP, Baeten D. 'MRI-tis' in the early diagnosis of axial SpA: issues and limitations. Nat Rev Rheumatol 2010, 6:666-669. 10.1038/nrrheum.2010.161, 20924412.